Research · Sep 3, 2026
PHAT: FY25 Deep Dive
Phathom Pharmaceuticals FY25 at $175M. NI $-221M; EPS $-3.03.
PHAT
Phathom Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.50
+4.97%NASDAQ · Healthcare · Biotechnology · US
Research · Sep 3, 2026
Phathom Pharmaceuticals FY25 at $175M. NI $-221M; EPS $-3.03.